Funder
Associazione "Salute con Stile"
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Reference33 articles.
1. P.M. Seferovi, M.C. Petrie, G.S. Filippatos, S.D. Anker, G. Rosano, J. Bauersachs, W.J. Paulus, M. Komajda, F. Cosentino, R.A. de Boer, D. Farmakis, W. Doehner, E. Lambrinou, Y. Lopatin, M.F. Piepoli, M.J. Theodorakis, H. Wiggers, Lekakis, A. Mebazaa, M.A. Mamas, C. Tschöpe, A.W. Hoes, J.P. Seferović, J. Logue, T. McDonagh, J.P. Riley, I. Milinković, M. Polovina, D.J. van Veldhuisen, M. Lainscak, A.P. Maggioni, F. Ruschitzka, J.J.V. McMurray, Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology. Eur. J. Heart Fail. 20, 853–872 (2018)
2. Y.J. Cheng, G. Imperatore, L.S. Geiss, S.H. Saydah, A.L. Albright, M.K. Ali, E.W. Gregg, Trends and disparities in cardiovascular mortality among U.S. adults with and without self-reported diabetes mellitus, 1988–2015. Diabetes Care 41, 2306–2315 (2018)
3. D. Giugliano, M.I. Maiorino, G. Bellastella, K. Esposito, Glycemic control in type 2 diabetes: from medication nonadherence to residual vascular risk. Endocrine 61, 23–27 (2018)
4. Food and Drug Administration, Guidance for Industry: Diabetes Mellitus—Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes (Food and Drug Administration, Silver Spring, Maryland, 2008). Available at:
www.fda.gov/downloads/Drugs/Guidances/ucm071627.pdf
5. C.K. Kramer, C. Ye, S. Campbell, R. Retnakaran, Comparison of new glucose-lowering drugs on risk of heart failure in type 2 diabetes. A network meta-analysis. JACC Heart Fail. 6, 823–830 (2018)
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献